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Abstract
Introduction Biophysical stimulation is a non-invasive therapy used in orthopaedic practice to increase and enhance reparative
and anabolic activities of tissue.
Methods A sistematic web-based search for papers was conducted using the following titles: (1) pulsed electromagnetic field
(PEMF), capacitively coupled electrical field (CCEF), low intensity pulsed ultrasound system (LIPUS) and biophysical stimu-
lation; (2) bone cells, bone tissue, fracture, non-union, prosthesis and vertebral fracture; and (3) chondrocyte, synoviocytes, joint
chondroprotection, arthroscopy and knee arthroplasty.
Results Pre-clinical studies have shown that the site of interaction of biophysical stimuli is the cell membrane. Its effect on bone
tissue is to increase proliferation, synthesis and release of growth factors. On articular cells, it creates a strong A2A and A3
adenosine-agonist effect inducing an anti-inflammatory and chondroprotective result. In treated animals, it has been shown that
the mineralisation rate of newly formed bone is almost doubled, the progression of the osteoarthritic cartilage degeneration is
inhibited and quality of cartilage is preserved. Biophysical stimulation has been used in the clinical setting to promote the healing
of fractures and non-unions. It has been successfully used on joint pathologies for its beneficial effect on improving function in
early OA and after knee surgery to limit the inflammation of periarticular tissues.
Discussion The pooled result of the studies in this review revealed the efficacy of biophysical stimulation for bone healing and
joint chondroprotection based on proven methodological quality.
Conclusion The orthopaedic community has played a central role in the development and understanding of the importance of the
physical stimuli. Biophysical stimulation requires care and precision in use if it is to ensure the success expected of it by
physicians and patients.
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Biophysical stimulation
Clinical biophysics forms the foundation of a Bnew
pharmacology^ which uses physical stimuli to treat various
diseases in human beings. Biophysical stimulation techniques
can be used in clinical medicine, either alone, to increase and
promote the repair and anabolic activity in tissue, or in asso-
ciation with drug treatment, to strengthen its activity and less-
en side effects. Clinical biophysics is an interdisciplinary sci-
ence which:
& Uses methods and theories from the field of physics to
study biological systems
& Studies how non-ionising physical stimuli interact with
biological systems
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The medical community is certainly familiar with the idea
of modifying the behaviour of a certain cellular activity using
a chemical agent or macromolecules, such as growth factors,
genes or a part of these. The ability to modify the activity of a
biological target using a physical agent, however, is a more
recent and unfamiliar discovery.
The ability of biological systems to absorb energy ini-
tially led researchers to focus their attention on dose as
the fundamental parameter on which Ball^ the effects de-
pend. Research then moved to the biological effects de-
pendent not only and not so much on the total energy
introduced into the system, as on the other properties
which describe the physical agent: frequency, amplitude
and the form of the signal wave.
The complexity of the interaction between physical agents
and biological systems has made the researchers’ work partic-
ularly difficult, and it is only today that we have acquired a
degree of knowledge such that physics can significantly help
the development of biology and lead to the opening of new
horizons where the clinical use of physical means is
concerned.
The methods for administrating physical energy to a
biological system are known as biophysical stimulation
and can be divided into electrical energy applied directly
to the tissue using adhesive electrodes (capacitively
coupled electrical field, CCEF), electromagnetic energy
applied using coils (pulsed electromagnetic fields,
PEMFs) and ultrasound energy applied directly to the tis-
sue in the form of mechanical forces (low intensity pulsed
ultrasound system, LIPUS).
Underlying the new pharmacology is the need to identify
the effects of the physical agents in terms of how these mod-
ulate a particular cell function, which will then form the basis
of its clinical application. The cell membrane has been iden-
tified as a target and site of interaction, through which the
physical signal activates a cascade of intracellular events; the
transduction pathways have been seen to differ depending on
the type of energy used (Fig. 1). Each time a physical agent is
able to modulate a cell activity, the effect observed will be
function-specific, rather than cell- or tissue-specific. This al-
lows all conditions which are positively influenced by the
activation or modulation of this cell function to be treated with
the same physical agent.
The key principles of biophysical stimulation are as
follows:
1. The ability of the physical stimulus to act selectively on
cell targets
2. Signal specificity, i.e. the effect depends on waveform,
frequency, duration and energy
3. Identification of the dose-response effects
4. The signal should maintain the characteristics identified
as being effective at the disease site.
Knowledge of the mechanism of action should provide the
rational basis for clinical application, permitting the clinical
studies and relative end-points to be designed in a coherent
manner.
Biophysical stimulation: in vitro studies
Effects of biophysical stimulation on bone cells
Numerous studies have analysed the effects of biophysical
stimulation on osteoblast proliferation and have highlighted
a dose-response effect for exposure times, PEMF intensity,
frequencies and signal waveforms [1, 2] (Fig. 2). More spe-
cifically, Brighton et al. [3] showed that a CCEF of 0.1–
10 mV/cm stimulates the proliferation of rat calvarial bone
cells, while lower intensities proved ineffective. In human
osteosarcoma cell lines and osteoblast cells in vitro, De
Mattei et al. [4] identified a relationship between PEMF ex-
posure times and the increase in proliferation, as well as dif-
ferences in exposure times between different cultures. Leung
et al. [5] studied the effect of LIPUS on cell cultures of human
periosteal cells, along with the effects in relation to time and
dosage. Total number of live cells, cell proliferation, alkaline
phosphatase activity, osteocalcin secretion and expression of
vascular endothelial growth factors were evaluated. The au-
thors demonstrated a clear dose-dependent effect, the greatest
efficacy being recorded at 20minutes exposure. Similar to that
reported for the proliferative effects, in vitro studies have
shown that in various cell models, biophysical stimulation
induces (i) an increase in osteoblast differentiation, promoting
the production of collagen and of the main matrix glycopro-
teins osteocalcin and osteopontin [6, 7]; (ii) stimulates the
mineralisation process [8, 9]; and (iii) plays an inhibitory role
in the process of osteoclast differentiation and exerts a protec-
tive action against osteolysis [10]. The increases induced by
biophysical stimulation in the production of bone matrix are
very similar to those induced by growth factors such as
TGF-β1, BMPs and growth factor IGF-I, indicating that the
effects induced by a biophysical stimulus are of significant
medical importance [11, 12] (Table 1).
Effects of biophysical stimulation on articular cells
Extensive in vitro data reported in literature shows the effect
of PEMFs on articular cells (Table 2). In bovine chondrocytes
and synoviocytes [13, 14], A2A and A3 adenosine receptors,
endogenous modulator of many biological processes such as
inflammation, increased in number in the presence of PEMFs,
reducing the release of PGE2, IL-6, IL-8 and COX-2, a result
which suggests a reduction in the inflammatory state and in
the degradation of cartilage associated with articular diseases.
Human synoviocytes treated with PEMFs reveal a significant
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increase in A2A and A3 adenosine receptors, as demonstrated
by the mRNA, Western blotting analysis and saturation bind-
ing experiments involving ARs, as well as a significant in-
crease in the release of IL-10, a known anti-inflammatory
cytokine [15]. The A2A and A3 receptors exert their anti-
inflammatory action by inhibiting the NF-κB transcription
factor pathway, which plays a central role in regulating the
synthesis and activities of the inflammatory cytokines.
Stimulation with PEMFs further inhibits the activation of
NF-κB and is essential for regulating the synthesis and acti-
vation of the pro-inflammatory cytokines, including TNF-α
and IL-1β, and also of other mediators involved in joint in-
flammation and bone diseases [16]. PEMFs have been shown
to affect the increase of human articular chondrocyte
proliferation, based on exposure time, intensity and frequency
[17]. It should be stressed that the effect of PEMFs on proteo-
glycan synthesis in human cartilage explants is comparable in
all senses to that induced by growth factor IGF-I, the principal
cartilage anabolic factor [18, 19]. While the presence of IL-1β
inhibits the synthesis of proteoglycans, exposure to PEMFs
can curb the catabolic effect of the cytokine, increasing pro-
teoglycan synthesis even under inflammatory conditions [20].
It is interesting to observe that these results regarding the anti-
inflammatory role of PEMFs are also confirmed in the stem
cell cultures [21].
Biophysical stimulation: in vivo studies
Effects of biophysical stimulation on bone repair
There are numerous studies in literature, performed in an-
imal models as early as the 1970s, which attest to the os-
teogenic effects of biophysical stimulation in bone repair.
In a 1974 study on dogs, Bassett et al. [22] demonstrated
the effect of PEMFs in stimulating the repair of a bilateral
fibular osteotomy, indicating the need to carry out further
studies to ascertain the physical characteristics of the signal
most effective in obtaining the biological effect desired. De
Haas et al. [23] also published a study whose objective was
to evaluate the effect of PEMFs at different frequencies in
an experimental rabbit osteotomy model, showing that the
treatment does not cause pathological alterations to the
Fig. 1 Schematic representation of the biophysical stimuli targets on the cell surface and corresponding metabolic pathways within the cell
Fig. 2 Effect of PEMF exposure length on human osteosarcoma cell lines
and human osteoblast cell (MG63) proliferation (Sollazzo et al.
Electricity and Magnetism in Biology and Medicine 1997)
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tissues and that different signal characteristics could result
in different outcomes. In transcortical holes bored in the
distal metaphysis and diaphysis of the third metacarpal
bone in horses, the histological results demonstrate that
PEMFs increase the quantity of newly deposited bone in-
side the hole from 40 to 120% more compared to the con-
trols and that the amount of newly deposited bone and
mineral apposition rate inside the holes are significantly
greater in the treated limbs compared to controls [24]
(Fig. 3). In 2005, Midura et al. [25] exposed rat
osteotomies to PEMF stimulation at two different frequen-
cies and intensities (15 Hz, 2 mT vs 1.5 Hz, 0.02 mT) with
Table 1 Biophysical stimulation on the regulation of bone matrix and growth factors
Author Physical method In vitro models Results
Jansen JH, BMCMusculoskelet Disord. 2010 PEMFs hBMSCs ↑ TGF-β1 ↑ BMP-2mRNA ↑ Differentiation
Esposito M, In Vivo. 2012 PEMFs hBMSCs ↑ Proliferation ↑ Differentiation
Ceccarelli G, Biores Open Access. 2013 PEMFs hBMSCs ↑ Proliferation ↑ ECM deposition
Zhou J, Bioelectromagnetics. 2013 PEMFs Rat calvarial osteoblasts ↑ Proliferation
Hartig M, Eur Biophys J. 2000 CCEF Osteoblast from periosteum explants ↑ Proliferation ↑ Differentiation
Wang Z, J Bone Joint Surg Am. 2006 CCEF Osteoblastic cells (MC3T3-E1) ↑ BMP-2,4,5,6,7 mRNA
Bisceglia B, Bioelectromagnetics. 2011 CCEF Osteoblast-like cell lines (SAOS-2) ↑ Proliferation
Clark CC, J Orthop Res. 2014 CCEF Human calvarial osteoblasts ↑ BMP-2,4 mRNA ↑ TGF-β1, β2, β3
mRNA ↑ FGF-2
Hauser J, J Orthop Res. 2009 LIPUS Osteoblast-like cell lines (SAOS-2) ↑ Proliferation
Fassina L, Bioinorg Chem Appl. 2010 LIPUS SAOS-2 human osteoblasts ↑ Proliferation ↑ ECM deposition
Xue H, PLoS One. 2013 LIPUS Alveolar bone in vivo ↑ BMP-2 mRNA
Carina V, J Appl Biomater Funct Mater. 2017 LIPUS Human mesenchymal stem cells ↑ Proliferation ↑MgHA/coll hybrid composite
scaffold ↑ VEGF gene expression
Table 2 Pulsed electromagnetic field effect in articular cells
Culture PEMF effects
Bovine chondrocytes and
synovial fibroblasts
Increase of A2A and A3 receptors
Increase of cellular proliferation
Inhibition PGE2 release
Bovine articular cartilage
explants
Increase of proteoglycan synthesis
Chondroprotective effect
Human synovial fibroblasts Inhibition of PGE2 IL-6, IL-8, and
TNF-α release
Stimulation of IL-10 release
Human articular cartilage
explants
Increase of proteoglycan synthesis
Counteract the catabolic activity of
IL-1b
Increase of cartilage explant anabolic
activities
Human T/C-28a2
chondrocytes
and hFOB 1.19
osteoblasts
Increase of A2A and A3 receptors
Inhibition of PGE2 IL-6, IL-8, and
VEGF release
Increase of cellular proliferation
Increase of osteoprotegerin (OPG)
production
Inhibition of NF-κB activation
Reduction of cAMP levels
Fig. 3 Effect of PEMF stimulation on mineral apposition rate in newly
formed trabeculae measured by tetracycline labelling, in transcortical
holes bored in the distal metaphysis and diaphysis of the third
metacarpal bone in horses (Canè Vet al. J Orthop Res 1993)
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similar results, showing that the higher frequency (15 Hz)
treatment led to a doubling of both the apposition rate and
the volume of the bone callus. The importance of the signal
characteristics was also studied for the CCEF and LIPUS
methods. In a 1985 study involving a rabbit fibular
osteotomy model, Brighton et al. [26] showed that only
the 60-KHz frequency, compared to those at 10 and
250 KHz, gave significantly better results than the controls
(Fig. 4). In 1994, Rijal et al. [27] created a non-union
experimental model, where a DEXA bone densitometry
scan showed an increase in density of 18% (p < 0.05) in
the CCEF group compared to the controls. In the 1980s,
Duarte [28] used LIPUS at a frequency of 1.5 MHz with
intensity of 30 mW/cm2 applied for 15 minutes/day in a
rabbit fibular osteotomy model, obtaining an increase of
28% in ossification in the limbs treated. A series of
in vivo studies followed in the 1990s, giving a better un-
derstanding of the ultrasound signal characteristics and
treatment times able to accelerate the bone healing process
in fractures. In bilateral rabbit fibular osteotomies, Pilla
[29] demonstrates that the application of LIPUS (200 μs
impulses at 1.5 MHz, at an intensity of 30 mW/cm2 for
20 min/day) accelerates bone healing by a factor of 1.7
compared to controls in terms of mechanical resistance.
The LIPUS applied have characteristics that have already
been approved by the FDA for use in clinical medicine for
20 minutes/day.
As clearly emerges from the studies illustrated,
obtaining the desired biological effect depends on the type
of signal used. For this reason, basic pre-clinical research is
fundamental for identifying the physical characteristics of
the stimulus able to interact with the biological system to
be influenced and in defining its value for clinical practice.
Effects of biophysical stimulation on articular
cartilage
Studies based on in vitro and ex vivo results have been per-
formed on large and small animal models to evaluate the effect
of PEMFs in preventing osteoarthrosic degeneration and in
the repair of tissue damage, as an adjunct to tissue engineering
methods.
In Dunkin Hartley guinea pigs [30], treatment with
PEMFs was demonstrated as being capable of halting
the progression of osteoarthrosis, of limiting cartilage sur-
face clefts and fibrillation, of preserving cartilage thick-
ness and of preventing sclerosis of the subchondral bone.
These results are coherent with those of other authors,
who have demonstrated an increase in TGF-β1 synthesis
and an inhibition of TNF-α synthesis (with a clear ana-
bolic and trophic effect on the articular cartilage) in the
animals treated using biophysical stimulation. Autologous
osteochondral autografts were performed in adult sheep
[31], resulting in a significantly better osteointegration
of the graft and a lesser formation of cyst-like resorption
areas in the PEMF group. The synovial liquid in the stim-
ulated animals contained significantly lower levels of pro-
inflammatory cytokines IL-1β and TNF-α and a higher
concentration of TGF-β1 compared to the untreated ani-
mals. PEMFs have proved effective in rabbits with
osteochondral lesions [32], significantly improving the
quality of the regenerated tissue in the osteochondral de-
fects in the presence of collagen scaffold and bone mar-
row concentrate.
The anti-inflammatory activity of PEMFs effectively
prevented the degenerative effect of IL-1β, significantly im-
proving cartilage regeneration compared to the non-stimulated
lesions, thus explaining the anti-degenerative, reparative and
anti-inflammatory effects of treatment with PEMFs in in vivo
models also.
Biophysical stimulation: clinical experiences
on bone tissue
Osteotomy
The first studies on the effect of biophysical stimulation
recognised as having level of evidence I status were three in
number and were conducted by the Italian orthopaedic com-
munity as early as the 1980s, on patients undergoing
osteotomy of the lower limbs. The studies report a significant
increase in the density of the trabecular bone callus in the
active group compared to the placebo group [33], a higher
consolidation success rate [34] and a shortening of consolida-
tion time by three months [35] (Fig. 5).
Fig. 4 Effect of CCEF frequency on fibula osteotomy healing in rabbits
(Brighton CT et al. J Orthop Res 1985)
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Fractures at risk of non-union
Biophysical stimulation has proved capable of accelerating
the healing of Bat-risk^ fractures treated by plaster casting or
internal or external fixation or complex fractures with serious
damage to soft tissues and exposure of bone tissue [36, 37]. In
patients with femur neck fractures, Faldini et al. [38] report a
percentage of healing of 94% in the PEMF group compared to
69% in the placebo group, while Benazzo et al. [39], using the
CCEF technique on athletes with stress fractures, observed a
reduction in functional recovery times with a success rate of
88%. In patients with fractures immobilised using plaster cast-
ing, external fixator or intramedullary nails, various authors
report a significant reduction of 38% in healing times using
LIPUS [40–43].
Non-unions
There is abundant clinical evidence in international literature
supporting the efficacy of biophysical stimulation on non-
union fractures, particularly with PEMFs; authors have report-
ed success rates of around 70–80% [44, 45] (Table 3). Good
results have also been obtained in the treatment of non-union
fractures with CCEFs and with LIPUS, albeit on a lesser scale.
Hip prostheses
Biophysical stimulation is an effective treatment for improv-
ing bone ingrowth in the presence of biomaterials and to pre-
vent complications deriving from the failure of the implant,
such as osteolysis.
In patients with painful uncemented hip prostheses,
Rispoli et al. [46] reported a clinically evaluated success
rate of good/excellent using PEMF treatment in 91% of
those who used the treatment for more than 360 hours,
compared to only 12% of non-compliant patients (<
360 hours). A few years later, Kennedy et al. [47] report-
ed a 53% success rate in patients with femoral component
loosening treated with PEMFs, compared to 11% of con-
trol patients. Dallari et al. [48] demonstrate that treatment
with PEMFs eases the relief of pain and aids in clinical
healing and the restoration of bone mass following revi-
sion total hip replacement.
Vertebral fractures
The first multi-centre study on 195 patients with anterior
or posterior lumbar fusion reports a 92% success rate in
the group stimulated with PEMFs, compared to 65% in
the control group [49]. A few years later, Linovitz et al.
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[50] reported a 64% bone fusion rate in the active group
after 9 months, compared to 43% in the placebo group
(p < 0.003). Over the last few years, stimulation with
CCEF has proved much more comfortable than inductive
stimulation, due to the ease of use of the applicators, with
fusion success rates of 84% [51] (Fig. 6). Beneficial ef-
fects on pain control and a reduced use of nonsteroidal
anti-inflammatory drug (NSAIDs) are also described in
literature. Rossini et al. [52] reported a significant pain
reduction in the active group compared to placebo, with
a consequent discontinuation of NSAIDs. Massari [53]
and Piazzolla et al. [54] demonstrate an improvement in
functional recovery following spinal fusion, and a signif-
icant reduction in the area of VBME in compression frac-
tures respectively, with pain resolution times reduced by
half.
Osteonecrosis
Santori et al. [55] found the association of PEMFs, core
decompression and grafts of trabecular bone tissue to be a
valid solution in delaying or preventing collapse of the
femoral head in the presence of osteonecrosis, with an
81% and 70% success rate in patients with Steinberg stage
II and Steinberg stage III osteonecrosis, respectively. The
most recent Italian study was conducted on 66 patients
with osteonecrosis of the hip, stimulated with PEMFs for
8 h/day [56]. At two month follow-up, 53% of patients no
longer reported any pain, and only 26% reported pain of
moderate intensity. Radiography results showed a progres-
sion of the degeneration in only 26% of the hips studied
(Table 4), and similar percentages have also been reported
by Cebrian [57].
Summary
None of the authors of these studies suggest a blanket use of
biophysical stimulation. In those cases in which the site, type
of exposure, morphology of the fracture or condition of the
patient indicate a risk of difficulties during the healing
process, the use of biophysical stimulation is justified as a
treatment to activate and finalise the process of osteogenesis
and to speed the recovery process.
Biophysical stimulation: clinical experience
on joint
Pre-clinical research shows that treatment with PEMFs is
anti-degenerative, helping to control local inflammatory
phenomena and supporting cartilage repair processes in
clinical setting (Table 5). Zorzi et al. [58] combined arthro-
scopic chondroabrasion and PEMF treatment. They showed
that the percentage of patients assuming NSAIDs is signif-
icantly lower in those patients treated with PEMF compared
to the placebo group and functional scores were signifi-
cantly better in the PEMF-treated group 90 days after sur-
gery. The recovery times for functionality of the knee were
significantly reduced in the short term and 87.5% of pa-
tients were unable to return to full sporting activity three
years after the procedure in the placebo group, compared to
37.5% in the active group (p < 0.05). Benazzo et al. [59]
have demonstrated that the percentage of patients using
NSAIDs following ACL reconstruction is significantly
lower in the patients treated with PEMFs compared to the
placebo group and that the time required for recovery of
knee function is significantly reduced in the short term.
Two years after the reconstruction of ACL, a complete
functional recovery was achieved by 86% of the patients
in the active group compared with 75% of the patients in the
placebo group. Similar results have been obtained follow-
ing treatment using collagen scaffold seeded with bone
marrow-derived cells for talar osteochondral lesions [60].
At six and 12 months follow-up, significantly higher
AOFAS score and significant lower pain were recorded in
the experimental group. More recently, Collarile et al. in
patients following matrix-assisted autologous chondrocyte
implantation (MACI) in the treatment of chondral lesions of
the knee [61] show that patients in the PEMFs group had
achieved a significantly better pain relief (2 and 6 months
Fig. 6 Representation of spinal
stimulation with PEMF device (a)
and CCEF device (b)
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follow-up) and clinical outcome at the time of the 60-month
follow-up. Two recent Italian studies [62, 63] on patients
undergoing total knee arthroplasty have shown that PEMFs
led to a significantly greater and more rapid reduction in
post-operative pain symptoms as early as the first month
and this was maintained at all follow-ups with a significant
difference compared to the control group. The same obser-
vation was made for swelling. The study by Adravanti,
which includes an evaluation 36 months after the proce-
dure, shows that at this time-point only 7% of the patients
in the PEMFs group still reported a level of persistent pain
requiring the use of anti-inflammatory drugs, compared to
33% of control group patients. Furthermore, no patient in
the PEMFs group expressed the need for walking aids com-
pared to approximately 20% of the control group. A study
conducted on patients in the early stages of osteoarthrosic
degeneration of the knee, treated conservatively with
PEMFs rather than surgically, showed significantly better
results in terms of functional recovery and pain resolution at
12months follow-up [64]. The author concludes that an an-
nual repetition of the treatment may result in sustained
symptomatic improvement for the patient. Similar im-
provements in joint function, pain resolution and time need-
ed to return to sporting activity were found in patients with
patellofemoral pain following treatment with PEMFs [65].
The effect of PEMFs has also been studied in patients in the
initial stages of spontaneous osteonecrosis of the knee [66],
with results showing a significantly reduced level of pain
after 6 months (p < 0.0001), an improvement in functional
recovery and a rapid return to sporting activity. These re-
sults remained constant even after 24 months. The MRI
evaluation at 6-month follow-up showed a significant re-
duction of total WORMS mean score (p < 0.0001).
Summary
PEMF therapy can therefore be used proactively as (i) post-
surgical treatment with the objective of quickly controlling
local inflammatory response due to the surgical operation
and, over the long term, to maintain the mechanical and bio-
logical properties of the cartilage or engineered tissue by
means of an effective chondroprotective effect; (ii) post-
arthroplasty treatment to inhibit the inflammatory processes
that affect the periarticular tissues and to avoid the develop-
ment of chronic pain and functional limitations; and (iii) con-
servative treatment to limit the progression of a degenerative
process such as osteoarthritis that comes with age and is ac-
celerated by inflammatory and/or traumatic events.
Biophysical stimulation: future perspectives
Today, numerous other areas of medicine are preparing to use
physical means to treat a variety of conditions or are seeing its
potential. Some applications are in their infancy or are still at the
stage of in vitro experimentation; however, current evidence
seems to suggest that these treatment approaches will become
increasingly widespread, for example in the treatment of
tendinopathies or in neurology. The effects of PEMFs, in fact,
have recently been studied on primary human cells isolated
from semitendinosus and gracilis tendons exposed to PEMFs:
results show that PEMFs do not alter cell vitality or induce
apoptotic phenomena but are able to induce responses at gene
expression level and to reduce the production of inflammatory
cytokines in the tendon cells [67]. In MSCs isolated from the
human umbilical cord and seeded in tendon differentiation me-
dium, PEMF showed a greater production of collagen type I,
scleraxis and greatest expression of tenogenic markers [68].
In neurology, there is great interest in the development of
novel therapies for acute ischaemic stroke because thromboly-
sis is the only approved treatment. PEMFs could represent an
alternative approach because of their effects on the main mech-
anisms of brain ischaemia. Capone et al. [69] demonstrated that
PEMF can influence cortical excitability and do not produce
side effects in healthy volunteers. Recently, a small, open-label,
one-arm, exploratory study to evaluate the safety of PEMF
stimulation in acute ischemic stroke (clinicaltrials.gov:
NCT01941147) has been designed [70]. Preliminary results
obtained in six patients demonstrated that a daily exposure of
120 minutes for five consecutive days is safe and tolerable.
Conclusion
Biophysical stimulation is the result of solid scientific research.
As reported in 2018 by Yuan et al., biophysical stimulation, as a
prospective, non-invasive and safe physical therapy strategy to
accelerate bone repair, has received tremendous attention in re-
cent decades [71]. Moreover, the promotion effect has shown
strikingly positive benefits in the treatment of various skeletal
diseases. In the USA and Europe, research on the use of physical
energy for bone repair processes has been ongoing throughout
the past century. Every year, tens of thousands of patients under-
go treatment all over the world. An inquiry to medical hospitals
in the USA found that 72% of interviewed were offering bio-
physical stimulation to patients with fractures not yet healed at
Table 4 Need for hip replacement by Ficat stage and progression of hip
degeneration
Ficat Hip replacement/number
of hips
Number of hips
(Ficat progression)
I 0/31 (0%) 3 (I➝ II)
II 3/22 (14%) 5 (II➝ III)
III 12/23 (52%) 12 (III➝ IV)
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three months from trauma [72]. A substantial proportion of
Canadian orthopaedic surgeons (45%) currently make use of
bone stimulators as part of their management strategy for at least
some tibial shaft fractures (for complicated tibial shaft fractures);
80% of respondents felt that a reduction in healing time of six
weeks or more, attributed to a bone stimulator, would be clini-
cally important [73]. More recently, in consideration of the sen-
sitivity of cartilage tissue to physical stimuli, the orthopaedic
community has now focused its interest on the joint to prevent
cartilage degeneration, to enhance cartilage repair and to favour
patients’ function recovery. Recently, Iwasa et al. have system-
atically reviewed the literature on the influence of PEMF in
joints, including articular cartilage, tendons and ligaments, of
publications from 2000 to 2016 [74]. The authors concluded that
PEMF has a beneficial effect on chondrocyte proliferation, ma-
trix synthesis and chondrogenic differentiation by upregulation
of TGF-b and BMPs, and it decreases anti-inflammatory cyto-
kines via A2A and A3 adenosine receptors leading in clinical
translational investigations, a beneficial effect on pain and func-
tions of OA knees.
The orthopaedic community has undoubtedly played a cen-
tral role in the development and understanding of the impor-
tance of physical stimuli to control biological activities.
Orthopaedic research has demonstrated that the effects are
dependent on physical parameters and, mediating from phar-
macology, has introduced the concept of physical dynamics.
Compared to drug treatment, biophysical stimulation has the
clear advantage that it can be administered locally with relative
ease and reach the disease site at its maximum Bconcentration^
and therapeutic efficacy, with no side effects. Biophysical treat-
ment appears to be effective for the prolonged treatment of
chronic degenerative conditions, while it does not seem suited
to treating systemic diseases. An important aspect of treatment
with physical agents is the ability to transfer the effects ob-
served in basic research to clinical practice. Further develop-
ment of the clinical use of physical agents involves overcoming
numerous and complex hurdles; however, the ability to recog-
nise and define an area with the potential for new treatment
approaches, such as clinical biophysics, is a fundamental step
in pointing the way for future research in various sectors.
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